RMQHX
Price
$626.31
Change
+$18.56 (+3.05%)
Updated
Aug 22 closing price
Net Assets
976.91M
RYCCX
Price
$444.75
Change
+$13.09 (+3.03%)
Updated
Aug 22 closing price
Net Assets
1.2B
Interact to see
Advertisement

RMQHX vs RYCCX

Header iconRMQHX vs RYCCX Comparison
Open Charts RMQHX vs RYCCXBanner chart's image
Rydex Monthly Rbl NASDAQ-100® 2x Strt H
Price$626.31
Change+$18.56 (+3.05%)
VolumeN/A
Net Assets976.91M
Rydex NASDAQ-100® 2x Strategy C
Price$444.75
Change+$13.09 (+3.03%)
VolumeN/A
Net Assets1.2B
RMQHX vs RYCCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RMQHX vs. RYCCX commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMQHX is a Buy and RYCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYCCX has more cash in the bank: 1.2B vs. RMQHX (977M). RMQHX pays higher dividends than RYCCX: RMQHX (0.21) vs RYCCX (0.00). RMQHX was incepted earlier than RYCCX: RMQHX (11 years) vs RYCCX (25 years). RYCCX (2.62) is less costly to investors than RMQHX (1.80). RMQHX is a more actively managed with annual turnover of: 1036.00 vs. RYCCX (383.00). RMQHX (2500) and RYCCX (2500) have matching initial minimum investment requirements. RYCCX annual gain was more profitable for investors over the last year : 19.60 vs. RMQHX (9.07). RMQHX return over 5 years is better than : 104.08 vs. RYCCX (90.78).
RMQHXRYCCXRMQHX / RYCCX
Total Expense Ratio1.272.5051%
Annual Report Gross Expense Ratio1.802.6269%
Fund Existence11 years25 years-
Gain YTD18.63114.872125%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets977M1.2B81%
Annual Yield % from dividends0.210.00-
Returns for 1 year9.0719.6046%
Returns for 3 years99.97120.3983%
Returns for 5 years104.0890.78115%
Returns for 10 years1321.47730.66181%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MC72.553.17
+4.57%
Moelis & Company
NTLA10.520.40
+3.90%
Intellia Therapeutics
EDIT2.800.07
+2.56%
Editas Medicine
MBBC10.420.09
+0.91%
Marathon Bancorp Inc
NOC592.44-4.77
-0.80%
Northrop Grumman Corp